Loading clinical trials...
Loading clinical trials...
Culturally-targeted Communication to Promote SARS-CoV-2 Antibody Testing in Saliva: Enabling Evaluation of Inflammatory Pathways in COVID-19 Racial Disparities
Conditions
Interventions
Culturally Targeted SARS-CoV-2 Communication
General SARS-CoV-2 Communication
Locations
1
United States
Flint Journal Building
Flint, Michigan, United States
Start Date
August 4, 2021
Primary Completion Date
December 19, 2022
Completion Date
December 19, 2022
Last Updated
June 28, 2024
NCT05115617
NCT04903132
NCT04470648
NCT06085547
NCT04896866
NCT05077969
Lead Sponsor
Michigan State University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions